Blood glucose control system switching without interruption of therapy delivery

US11123485B2 · kind B2 · utility

Assignee

• Beta Bionics, Inc.

Inventors

• Himanshu Patel · Rancho Santa Margarita, US
• Michael J. Rosinko · Las Vegas, US
• Edward R. Damiano · Acton, US
• David Chi-Wai Lim · Irvine, US
• Firas H. El-Khatib · Brookline, US
• John R. Costik · Livonia, US
• Justin P. Brown · Tustin, US
• Bryan D. Knodel · Cincinnati, US

Key dates

• Filing date: Oct 2, 2020
• Grant date: Sep 21, 2021
• Expiry date: Oct 2, 2040

Classification

• Technology area (CPC G): Physics
• CPC primary: G16H40/00
• WIPO field: Medical technology
• WIPO sector: Instruments

Abstract

Systems and methods are disclosed herein for switching an application executing on an ambulatory medical device to a new application without interrupting therapy provided by the ambulatory medical device to a subject. The ambulatory medical device may receive an indication that an update to an application executing on the ambulatory insulin pump is available, establish a communication connection to a host computing system, download and install the application update, while a prior version of the application continues to run. The disclosed systems and methods can confirm successful installation of the application update on the ambulatory medical device and switch control of the ambulatory medical device from the prior version to the new version of the application without interrupting therapy provided to the subject.